Sunday, April 07, 2024 9:45:09 AM
How am I wrong? I'm literally just listing a bunch of dates in line with what we've been told by the company and historic metrics from the MHRA. They requested the 150 day pathway. That doesn't include a RFI, which they themselves said is very possible. It's crazy that people view 150 days as too long, when we're only 40-50 days away and history says that would very much be considered a quicker than average assessment.
If you think it'll be earlier, that's great! My posts are simply a REALISTIC reference tool. I'd love for it to be quicker than 150 days, trust me. But nobody has any real evidence that this could set a new standard for assessment length. I don't want to be giving false hope like so many on this board are so good at doing. A bunch of the same crowd said we would have approval within 30-80 days from submission. Shocker, that turned out to be wrong, again. My posts could list every single possible approval date, would that make you happy? Fact is, PERSONALLY, I believe a 210 day assessment is more likely than a 120 day (next week) assessment. That's my opinion. You can have yours.
If you think it'll be earlier, that's great! My posts are simply a REALISTIC reference tool. I'd love for it to be quicker than 150 days, trust me. But nobody has any real evidence that this could set a new standard for assessment length. I don't want to be giving false hope like so many on this board are so good at doing. A bunch of the same crowd said we would have approval within 30-80 days from submission. Shocker, that turned out to be wrong, again. My posts could list every single possible approval date, would that make you happy? Fact is, PERSONALLY, I believe a 210 day assessment is more likely than a 120 day (next week) assessment. That's my opinion. You can have yours.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
